Related Experiment Video

Updated: Jun 16, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment

G L Beretta1, G Cossa, L Gatti

  • 1Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, viaVenezian 1, 20133 Milan, Italy.

Current Medicinal Chemistry
|February 20, 2010
PubMed

Insights

Targeting DNA repair enzyme Tyrosyl-DNA phosphodiesterase 1 (TDP1) may enhance antitumor therapy. TDP1 repairs DNA damage from topoisomerase 1 (Top1) poisons like camptothecins, potentially causing tumor resistance.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • DNA Repair Mechanisms

Background:

  • Antitumor therapies often induce DNA damage.
  • Tumor cells can develop resistance to DNA damaging agents through enhanced repair pathways.
  • Topoisomerase 1 (Top1) poisons, such as camptothecins, are clinically relevant antitumor agents whose efficacy is linked to DNA lesion generation.

Purpose of the Study:

  • To review the role of Tyrosyl-DNA phosphodiesterase 1 (TDP1) in DNA repair.
  • To explore TDP1's function in counteracting DNA damage induced by camptothecins.
  • To discuss TDP1's cooperation with other DNA repair pathways and the development of pharmacological inhibitors.

Main Methods:

  • Literature review of studies on TDP1 function in DNA repair.
  • Analysis of TDP1's role in repairing Top1/DNA complexes.
  • Examination of evidence linking TDP1 activity to camptothecin resistance.

Main Results:

  • TDP1 is implicated in repairing DNA strand breaks by processing abortive Top1/DNA complexes.
  • A role for TDP1 in counteracting camptothecin-induced DNA damage has been proposed.
  • TDP1's involvement in resistance mechanisms against DNA damaging agents is suggested.

Conclusions:

  • TDP1 plays a significant role in DNA repair, particularly in resolving Top1-mediated DNA damage.
  • Understanding TDP1 function is crucial for developing strategies to overcome therapeutic resistance.
  • Targeting TDP1 presents a promising approach to enhance the efficacy of antitumor therapies.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...